期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

急性心力衰竭患者脑钠肽和高敏C反应蛋白水平分析 被引量：3

Clinical significance of detection of brain natriuretic peptide and high sensitive C-reactive protein in the serum of patients with acute heart failure
原文传递
导出
摘要 目的研究急性心力衰竭患者血清脑钠肽(BNP)和高敏C反应蛋白(hs-CRP)在治疗前后的水平变化,探讨其临床价值。方法测定35例急性心力衰竭患者治疗前后脑钠肽(BNP)和高敏C反应蛋白(hs-CRP)水平,并与31例正常对照组比较。结果急性心力衰竭患者治疗前后比较及分别与正常组比较,脑钠肽(BNP)和高敏C反应蛋白(hs-CRP)水平有显著差异,P<0.005。结论脑钠肽(BNP)和高敏C反应蛋白(hs-CRP)对急性心力衰竭诊断有重要意义,可作为观察的一个重要参数。 Objective To analyze the levels of serum brain natriuretic peptide （BNP） and high sensitive C-reactive protein in patients with acute heart failures. Methods The levels of serum BNP and hs-CRP from 35 acute heart failure patients were measured ,analyzed and compared with 31 healthy individuals. Results The re significant differences in levels of serum BNP and hs-CRP between the acute heart failure group and healthy group were observed （P〈0.005）. Conclusion BNP and hs-CRP are are two important indicators for diagnosis of acute heart failure.
作者 方快发 吴平生
机构地区 南方医科大学附属南方医院心内科
出处 《中国热带医学》 CAS 2009年第5期884-885,共2页 China Tropical Medicine
关键词 急性心力衰竭 脑钠肽 高敏C反应蛋白 Acute heart failure Brain natriuretic peptide（BNP） High sensitive C-reactive protein（hs-CRP）
分类号 R541.61 [医药卫生—心血管疾病]
  • 相关文献

参考文献7

  • 1Groenning BA,Nilsson JC,Sondergaard L,et al. Evaluation of impaired left ventricular ejection fraction and increased dimensions by muitipule neurohumoral plasma concentyations[J ]. Euy J Heart Fail, 2001,3: 699-708.
  • 2Stanek B,Frey B,Hulsmann M,et al . Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction [J] . J Am Coll Cardiol, 2001,38: 436-442.
  • 3Ridker PM, Hennekens CH, Stampfer M J, et al. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men [J] . Lancet, 1998,351(1): 88.
  • 4史瑞英,王丹,黎辉.血浆脑钠素在心衰诊断及治疗中的应用价值[J].中国实用内科杂志,2004,24(11):701-702. 被引量：20
  • 5Krishnaswamy P, Lubien E, Clopton P, et al. Utillity of BNP levels in identifying patients with left ventrieular systolle or diastolic dysfunction[ J ]. AM J Med, 2001,111 (4): 274-279.
  • 6Asada J,Tsuji H,Iwasaka T,et al . Usefulness of plasma brain natriuretic peptide levels in predicting dobutam ine-induced myocardial isehemia[J]. AM J Cardiol,2004,93:702-704.
  • 7Hoffmeister HM,Ehlers R,Buttcber,et al. Relationship between minox myocardial damage and inflammatoxy acute phase reaction in acute coronary syndromes[ J ]. J Thromb Thrombolysis, 2003,15(1):33.

二级参考文献9

  • 1Maisel AS,Koon J,Krishnaswamy P,et al.Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction.Am Heart J,2001,141(3):367-374
  • 2McDonagh TA,Robb SD,Murdoch DR,et al.Biochemical detection of left-ventricular systolic dysfunction.Lancet,1998,351(9095):9-13
  • 3Lubien E,DeMaria A,Krishnaswamy P,et al.Utility of B-natriuretic peptide in detecting diastolic dysfunction:comparison with Doppler velocity recordings.Circulation,2002,105(5):595-601
  • 4Villacorta H,Duarte A,Duarte NM,et al.The role of B-type natriuretic peptide in the diagnosis of congestive heart failure in patients presenting to an emergency department with dyspnea.Arq Bras Cardiol,2002,79(5):569-572
  • 5Maisel AS,McCord J,Nowak RM,et al.Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction.J Am Coll Cardiol,2003, 41(11):2010-2017
  • 6Cheng V,Kazanagra R,Garcia A,et al.A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure.J Am Coll Cardiol,2001,37(2):386-391
  • 7Richards AM,Doughty R,Nicholls MG,et al.Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction.Australia-New Zealand Heart Failure G
  • 8Murdoch DR,McDonagh TA,Byrne J,et al.Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration:randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical the
  • 9Troughton RW,Frampton CM,Yandle TG,et al.Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations.Lancet,2000, 355(9210):1126-1130

共引文献19

同被引文献56

  • 1Peacock WF, Hollander JE, Diereks DB, et al. Morphine and outcomes in acute decompensated heart failure : an ADHERE analysis [ J ]. Emerg Med J, 2008, 25 (4) :205-209.
  • 2Hemandez AF, Hammill BG, OConnor CM, et al. Clinical effectiveness of be-ta-blockers in heart failure: findings from the OPTIMIZE-HF ( Organized Pro- gram to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry [J]. J Am Coll Cardiol,2009,53(2) :184-192.
  • 3Nieminen MS, Brutsaert D, Dickstein K, et al. EuroHeart Failure Survey Ⅱ : a survey on hospitalised acute heart failure patients: description of population [J]. Eur Heart J,2006,27:2725-2736.
  • 4Brannwald. Braunwald's Heart Disease[ M ]. 9th ed. 2011.
  • 5Harjola VP, Follath F, Nieminen MS, et al. Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospi',alized for acute heart failure[ J] . Eur J Heart Fail, 2010,12(3) :239-248.
  • 6Masson S, Latini R,Anand IS,et al. Direct comparison of B-type natriuretic peptlde (BNP) arm amino-terminal pmBNP in a large population of patients with chronic and symptomatic heart failure:The Valsartan Heart Failure (ValHEFT) Data[J]. Clin Chem,2006,5(8) :1528-1538.
  • 7Jemberg T, Lindahl B, Siegbahn A, et al, Pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy inunstable coronary artery disease[ J]. J Am Coll Cardiol,2003,42 ( 11 ) : 1909- 1916.
  • 8Abraham WT, Fonarow GC, Albert NM, et al. Predictors of in-hospital mar- tality in patients hospitalized for heart failure : insights from the Organized Pro- gram to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) [ J]. J Am Coll Cardiol,2008, 52(5) :347-356.
  • 9Hoffmeister HM, Ehlers R, Buttcher, et at. Relationship between minox myocar- dial damage and infiammatoxy acute phase reaction in acute coronary syn- dromes [ J ]. Thromb Thrombolysis ,2003,15 ( 1 ) : 33 -39.
  • 10Kociol RD, Pang PS, Gheorghiade M, et al. Troponin elevation in patients with heart failure [J]. J Am Coll Cardiol, 2010,56:1071-1078.

引证文献3

二级引证文献45

中国热带医学
2009年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部